Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 152

1.

Apolipoprotein E alleles, dyslipidemia, and coronary heart disease. The Framingham Offspring Study.

Wilson PW, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ.

JAMA. 1994 Dec 7;272(21):1666-71.

PMID:
7966894
2.

Metabolic factors clustering, lipoprotein cholesterol, apolipoprotein B, lipoprotein (a) and apolipoprotein E phenotypes in premature coronary artery disease in French Canadians.

Weber M, McNicoll S, Marcil M, Connelly P, Lussier-Cacan S, Davignon J, Latour Y, Genest J Jr.

Can J Cardiol. 1997 Mar;13(3):253-60.

PMID:
9117913
3.

Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels. Results from the Framingham Offspring Study.

Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, Wilson PW.

Arterioscler Thromb. 1994 Jul;14(7):1105-13.

4.

Genetic predictors of coronary heart disease risk factors in premenopausal African-American women.

Giger JN, Strickland OL, Weaver M, Taylor H, Acton RT.

Ethn Dis. 2005 Spring;15(2):221-32.

PMID:
15825968
5.

APOE genotype, lipids, and coronary heart disease risk: a prospective population study.

Ward H, Mitrou PN, Bowman R, Luben R, Wareham NJ, Khaw KT, Bingham S.

Arch Intern Med. 2009 Aug 10;169(15):1424-9. doi: 10.1001/archinternmed.2009.234. Erratum in: Arch Intern Med. 2009 Dec 14;169(22):2108.

PMID:
19667307
6.
7.

[Interaction of ApoE and LDL-R gene polymorphisms and alcohol drinking and smoking on coronary heart disease].

Wang CH, Zhou X, Zhou GD, Han DF, Zheng F.

Zhonghua Yi Xue Za Zhi. 2004 Apr 2;84(7):554-8. Chinese.

PMID:
15144588
9.

Cholesteryl ester transfer protein TaqI B2B2 genotype is associated with higher HDL cholesterol levels and lower risk of coronary heart disease end points in men with HDL deficiency: Veterans Affairs HDL Cholesterol Intervention Trial.

Brousseau ME, O'Connor JJ Jr, Ordovas JM, Collins D, Otvos JD, Massov T, McNamara JR, Rubins HB, Robins SJ, Schaefer EJ.

Arterioscler Thromb Vasc Biol. 2002 Jul 1;22(7):1148-54.

11.

Apolipoprotein E polymorphism in American Indians and its relation to plasma lipoproteins and diabetes. The Strong Heart Study.

Kataoka S, Robbins DC, Cowan LD, Go O, Yeh JL, Devereux RB, Fabsitz RR, Lee ET, Welty TK, Howard BV.

Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):918-25.

12.

Metabolic dyslipidemia and risk of future coronary heart disease in apparently healthy men and women: the EPIC-Norfolk prospective population study.

Rana JS, Visser ME, Arsenault BJ, Després JP, Stroes ES, Kastelein JJ, Wareham NJ, Boekholdt SM, Khaw KT.

Int J Cardiol. 2010 Sep 3;143(3):399-404. doi: 10.1016/j.ijcard.2009.03.123. Epub 2009 Apr 26.

PMID:
19394708
14.

Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group.

Wilt TJ, Rubins HB, Collins D, O'Connor TZ, Rutan GH, Robins SJ.

Arch Intern Med. 1996 Jun 10;156(11):1181-8.

PMID:
8639012
15.

Influences of common variants of apolipoprotein E on measures of lipid metabolism in a sample selected for health.

Xhignesse M, Lussier-Cacan S, Sing CF, Kessling AM, Davignon J.

Arterioscler Thromb. 1991 Jul-Aug;11(4):1100-10.

16.

Effects of age, gender, and menopausal status on plasma low density lipoprotein cholesterol and apolipoprotein B levels in the Framingham Offspring Study.

Schaefer EJ, Lamon-Fava S, Cohn SD, Schaefer MM, Ordovas JM, Castelli WP, Wilson PW.

J Lipid Res. 1994 May;35(5):779-92.

17.

Apolipoprotein E gene polymorphism and gender.

Kolovou G, Damaskos D, Anagnostopoulou K, Cokkinos DV.

Ann Clin Lab Sci. 2009 Spring;39(2):120-33. Review.

PMID:
19429797
18.

Apolipoprotein E isoform polymorphisms are not associated with insulin resistance: the Framingham Offspring Study.

Meigs JB, Ordovas JM, Cupples LA, Singer DE, Nathan DM, Schaefer EJ, Wilson PW.

Diabetes Care. 2000 May;23(5):669-74.

19.

Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham Offspring Study.

Schaefer EJ, Lamon-Fava S, Ordovas JM, Cohn SD, Schaefer MM, Castelli WP, Wilson PW.

J Lipid Res. 1994 May;35(5):871-82.

20.

Clinical utility of different lipid measures for prediction of coronary heart disease in men and women.

Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PW, D'Agostino RB, Vasan RS.

JAMA. 2007 Aug 15;298(7):776-85.

PMID:
17699011
Items per page

Supplemental Content

Write to the Help Desk